Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

Dr. Christopher McGowan, MD, an obesity medicine specialist at True You Weight Loss, says the decision to drink on Ozempic is ...

Some fear weight-loss stocks are approaching bubble territory, but this incumbent player continues to prove its worth ...

A QUARTER of a million more Brits will be put on NHS fat jabs in the next three years under plans to crush England’s obesity crisis. Super-strong tirzepatide, which can help slimmers lose a ...

Many types of physicians are now prescribing GLP-1 receptor agonist medications for weight loss ... if not obesity medicine, is best equipped to watch for long-term changes like muscle loss, ...

Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market ... to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion ...

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

Does drinking water help you lose weight? Believe it or not, it can. While this might sound too good to be true, there’s some ...

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and ...

The NHS plans to roll out Mounjaro, a weight-loss jab that can help users lose up to a quarter of their body weight, making it more potent than Ozempic. Anna Magee explains how to choose the best opti ...

Green tea, coffee, protein, fiber, and high-water foods can curb your appetite and help you stay fuller for longer. Here, ...